NO121045B - - Google Patents

Download PDF

Info

Publication number
NO121045B
NO121045B NO169099A NO16909967A NO121045B NO 121045 B NO121045 B NO 121045B NO 169099 A NO169099 A NO 169099A NO 16909967 A NO16909967 A NO 16909967A NO 121045 B NO121045 B NO 121045B
Authority
NO
Norway
Prior art keywords
benzoxazin
carbon atoms
alkyl group
alkyl
mean hydrogen
Prior art date
Application number
NO169099A
Other languages
English (en)
Norwegian (no)
Inventor
L Bernardi
L Pegrassi
S Coda
G Suchowsky
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of NO121045B publication Critical patent/NO121045B/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO169099A 1966-08-03 1967-09-29 NO121045B (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2105166 1966-08-03
IT1800566 1966-08-03
IT1516667 1967-04-20

Publications (1)

Publication Number Publication Date
NO121045B true NO121045B (cs) 1971-01-11

Family

ID=27272868

Family Applications (2)

Application Number Title Priority Date Filing Date
NO169228A NO121275B (cs) 1966-08-03 1967-08-01
NO169099A NO121045B (cs) 1966-08-03 1967-09-29

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO169228A NO121275B (cs) 1966-08-03 1967-08-01

Country Status (13)

Country Link
US (1) US3526621A (cs)
BE (2) BE702201A (cs)
CH (1) CH478828A (cs)
DE (2) DE1695756C3 (cs)
DK (2) DK118877B (cs)
ES (2) ES343737A1 (cs)
FR (2) FR6494M (cs)
GB (1) GB1135899A (cs)
IL (1) IL28427A (cs)
NL (2) NL6710332A (cs)
NO (2) NO121275B (cs)
SE (2) SE331997B (cs)
YU (2) YU31634B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301283A (en) * 1979-09-27 1981-11-17 Sterling Drug Inc. Process for preparing 2-oxo-dihydrobenzo(d)(1,3)-oxazines
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
DE3217012A1 (de) * 1982-05-06 1983-11-10 Dr. Karl Thomae Gmbh, 7950 Biberach Benzoxazin-2-one, deren herstellung und diese verbindungen enthaltende arzneimittel
US5665720A (en) * 1992-08-07 1997-09-09 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
AU1694295A (en) * 1994-01-28 1995-08-15 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5874430A (en) * 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
EP1359147A1 (en) * 1996-10-02 2003-11-05 Bristol-Myers Squibb Pharma Company 4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and processes for making the same
US5932726A (en) * 1996-12-16 1999-08-03 Dupont Pharmaceuticals Company Asymmetric synthesis of benzoxazinones
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
US7514466B2 (en) * 2004-04-27 2009-04-07 Wyeth Purification of progesterone receptor modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2940971A (en) * 1960-06-14 Tetrahydrooxazenones
US3047573A (en) * 1962-07-31 N-alkylamido substituted
US1951807A (en) * 1931-04-17 1934-03-20 Holimann La Roche Inc 4-phenalkyl-3-keto-3.4-dihydro-1.4-benzoxazines and process for the manufacture of same
US2947745A (en) * 1958-08-11 1960-08-02 Smith Kline French Lab Substituted phenoxazine sedative agents
US3280120A (en) * 1964-03-09 1966-10-18 Rexall Drug Chemical Substituted benzoxazines, process therefor and intermediates

Also Published As

Publication number Publication date
YU152667A (en) 1973-02-28
YU190067A (en) 1973-02-28
DE1695780B2 (de) 1978-12-21
YU31636B (en) 1973-10-31
DE1695756C3 (de) 1978-10-05
DE1695756B2 (de) 1978-02-09
DE1695756A1 (de) 1972-03-02
NO121275B (cs) 1971-02-08
BE702201A (cs) 1968-02-02
GB1135899A (en) 1968-12-04
DK118877B (da) 1970-10-19
NL6710332A (cs) 1968-02-05
SE337823B (cs) 1971-08-23
FR93909E (fr) 1969-06-06
SE331997B (cs) 1971-01-25
FR6494M (cs) 1968-11-25
BE704583A (cs) 1968-04-02
CH478828A (de) 1969-09-30
ES345647A2 (es) 1968-11-16
NL6713047A (cs) 1968-10-21
YU31634B (en) 1973-10-31
ES343737A1 (es) 1968-10-16
DK111568B (da) 1968-09-16
US3526621A (en) 1970-09-01
DE1695780A1 (de) 1971-04-29
IL28427A (en) 1971-04-28
DE1695780C3 (de) 1979-08-23

Similar Documents

Publication Publication Date Title
NO121045B (cs)
US3818032A (en) Substituted 1-phenyl-2,5-dioxo imidazolidines
Tribak et al. Synthesis and reactivity of new heterocyclic systems derived from 5-chloro-1H-indole-2, 3-dione
DE941288C (de) Verfahren zur Herstellung substituierter 2-Imino-4-thiazoline oder von Salzen derselben bzw. von substituierten 2-Aminothiazolen
EP0579939B1 (de) Neue Phospholipidderivate
DE1912941C3 (de) 1 -Phenyl^-amino-e-methoxypyridaziniumsalze
JPS6048959A (ja) ２−アダマンタノンオキシムのエステル
US2586844A (en) Preparation of delta2-1, 3-diazacycloalkenes
US2768202A (en) Glycinamide derivatives
DE19853558A1 (de) Verfahren zur Herstellung von 2,3-Dihydroindolen (Indolinen), neuartige 2,3-Dihydroindole sowie deren Verwendung
US2748129A (en) Sulfamylpiperazines and method of preparing the same
RU2059626C1 (ru) СПОСОБ ПОЛУЧЕНИЯ ТРИБРОМИДА ТРИС( β -ДИЭТИЛБЕНЗИЛАММОНИО)ЭТИЛОВОГО ЭФИРА ИЗОЦИАНУРОВОЙ КИСЛОТЫ
US2489354A (en) Benzotriazines
US3647785A (en) Novel 3-indolylaliphatic acid anhydrides
Vovk et al. 4-Nitrophenyl N-(1-Aryl-2, 2, 2-trifluoroethylidene) urethanes: Novel 1, 3-Electrophilic Components of Reactions Leading to 6-and 7-Membered Heterocycles
Yatagai et al. Proton NMR studies of alkenylboranes. The presence of diastereomers in certain alkenylboranes
US3122548A (en) S-phenethyloxy carbonyl thiamine o-monophophosphate and the hydrochloride thereof
Hünsch et al. Synthesis and phosphorylating properties of 2‐chloro‐2, 3‐dihydro‐3‐(methylsulfonyl)‐1, 3, 2‐benzoxazaphosphole 2‐oxide. Derivatives with chloro substituents on the benzene ring
US3062816A (en) New derivatives of the gh-i
Borsus et al. A new synthetic method for 5-sulfonylimino-1, 4, 2-oxathiazoles
DE1620319C (de) Verfahren zur Herstellung von Aziridinen
Kaye Dimethyl N-(Phenyl-, 2-Pyridyl-, and 3-Phenylpropyl)-aminoacetals
US3364228A (en) 3-hydroxymethyl-4-(indol-3-yl)-hexahydro-1h-azepines and method of preparation
DE2306001C3 (de) Pyrimidinderivate, Verfahren zu deren Herstellung und diese enthaltende Geflügelfutterzusammensetzungen
Grigor'ev et al. Reactions of γ-sultines with electrophilic reagents. 2. Bromination of 3, 5-diaryl-1, 2-oxathiolane 2-oxides in the presence of Lewis acids